
Keywords: cVDPV; circulating (demonstrating sustained person-to-person transmission) vaccine-derived poliovirus; mOPV2; monovalent oral polio vaccine containing only Sabin 2; NP-AFP; non-polio acute flaccid paralysis; OPV; oral polio vaccine; RI; routine immunizati